Together is a new resource for anyone affected by pediatric cancer - patients and their parents, family members, and friends.Learn More
Often used for:
Hepatocellular carcinoma, Renal cell carcinoma, Thyroid cancer, Acute myeloid leukemia
Sorafenib is a type of medicine called a targeted therapy. This medicine is a tyrosine kinase inhibitor or vascular endothelial growth factor (VEGF) inhibitor. It acts to block certain cell signals to help keep cells from growing. It can also help block the growth of blood vessels that supply oxygen to tumors.
Patients will have regular blood draws to check blood counts and monitor liver and kidney function. The dose of sorafenib may change based on results of lab tests.
May be taken as a tablet by mouth
Not all patients who take sorafenib will experience these side effects. Common side effects are in bold, but there may be others. Please report all suspected side effects to your doctor or pharmacist.
Be sure to discuss these and other recommendations with your doctor or pharmacist.
Sorafenib at home: